Date of appointment: Board of Directors of 11 January 2021 (cooptation) and General Meeting of 27 May 2021 (ratification)
Date of renewal: General Meeting of 15 June 2023
End of term of office: General Meeting convene to approve the financial statements for the year ending 31 December 2025
Having graduated from the École Polytechnique and École des Mines de Paris in 2000, Mr Guillaume Bouhours began his career in the financial sector, first at Morgan Stanley Investment Banking (in London and Paris) and, from 2004, at Sagard Private Equity Partners, where he became Investment Director in 2007.
From 2010 to 2017, he was Chief Financial Officer of Faiveley Transport, a company specialising mainly in the rail transport sector, in which he was also a member of the Management Board and the Management Committee. From 2017 to 2018, he served as President of the Access and Mobility Division and President of the China Region at Wabtec Corporation.
He is currently Executive Vice President in charge of Finance, Purchasing and Information Systems at bioMérieux Group, a world leader in in vitro diagnostics of infectious diseases, know for its research, development and innovation in the field of health, and listed on Euronext Paris.